PeptideAgentAsk PeptideAgent
Browse / Entity classes

Understand the class before comparing the product.

Mechanism and class pages connect related records while keeping product identity, route, approval, and evidence maturity separate.
01

Incretin receptor agonists

Approved and investigational GLP-1, GIP, and glucagon receptor agonists used or studied in metabolic medicine.

Open class guide
02

Growth-hormone-axis peptides

GHRH analogs and growth-hormone secretagogues with sharply different clinical and regulatory histories.

Open class guide
03

Thymosin-related peptides

Thymosin alpha-1, thymosin beta-4, and TB-500 records where identity is central to evidence transfer.

Open class guide
04

Mitochondrial and mitochondrial-targeted peptides

Endogenous mitochondrial signaling and mitochondrial-targeted drug research kept separate from commercial longevity claims.

Open class guide
05

Melanocortin agonists

Approved bremelanotide evidence and unapproved Melanotan II claims compared by product and indication.

Open class guide
06

Neuroactive research peptides

Semax, Selank, and DSIP research organized around the limits of human evidence and route-specific claims.

Open class guide
07

Innate-immunity and inflammation peptides

Host-defense and immune-signaling peptides discussed without translating laboratory activity into treatment claims.

Open class guide
08

Repair and extracellular-matrix peptides

BPC-157, GHK-Cu, thymosin beta-4, and TB-500 evidence separated by entity, route, and human relevance.

Open class guide